Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.72 -0.14 (-2.77%)
As of: Aug 21, 2026 · 2:18 PM EDT

Verrica Pharmaceuticals (VRCA) Finished Goods (2023 - 2025)

Verrica Pharmaceuticals (VRCA) posted quarterly Finished Goods of $991000.0 for Q2 2025, up 13.65% year-over-year from $872000.0 in Q2 2024, and down 19.69% quarter-over-quarter from $1.2 million in Q1 2025.

Verrica Pharmaceuticals (VRCA) Finished Goods (2023 - 2025) Analysis & Trends

Verrica Pharmaceuticals' Finished Goods history runs 3 years deep, the most recent figure standing at $991000.0 for Q2 2025.

  • In Q2 2025, Finished Goods rose 13.65% year-over-year to $991000.0; the TTM figure through Jun 2025 stood at $991000.0 (up 13.65% YoY), while the FY2024 annual figure was $717000.0, up 523.48% from the prior year.
  • Finished Goods for Q2 2025 stood at $991000.0, down from $1.2 million in the prior quarter.
  • The five-year high for Finished Goods was $1.2 million in Q1 2025, with the low at $115000.0 in Q4 2023.
  • The 3-year median for Finished Goods is $699000.0 (2024), against an average of $674875.0.
  • The sharpest annual moves came in 2024 and 2025: Finished Goods soared 523.48% in 2024, then gained 13.65% in 2025.
  • Verrica Pharmaceuticals' Finished Goods stood at $115000.0 in 2023, then jumped by 523.48% to $717000.0 in 2024, then jumped by 38.21% to $991000.0 in 2025.
  • Business Quant data shows VRCA's Finished Goods at $991000.0 in Q2 2025, $1.2 million in Q1 2025, and $717000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.93 Bn 131.08 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.11 Bn 78.11 Bn 3.93 Bn
3 Argenx Se 65.43 Bn 60.25 Bn 1.37 Bn
4 Moderna 56.09 Bn 50.96 Bn 52.00 Mn
5 BeOne Medicines 42.13 Bn 37.03 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 27.68 Bn 9.29 Bn 668.28 Mn
8 Insmed 27.49 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.36 Bn 26.52 Bn -
10 Verrica Pharmaceuticals 101.10 Mn 89.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 991,000.00
Mar 31, 2025 1.23 Mn
Dec 31, 2024 717,000.00
Sep 30, 2024 626,000.00
Jun 30, 2024 872,000.00
Mar 31, 2024 681,000.00
Dec 31, 2023 115,000.00
Sep 30, 2023 163,000.00